Advertisement

HindustanTimes Fri,21 Nov 2014

Pfizer says keen to engage with AstraZeneca board

Reuters  London, May 13, 2014
First Published: 11:49 IST(13/5/2014) | Last Updated: 11:52 IST(13/5/2014)

US drugmaker Pfizer kept up the pressure on bid target AstraZeneca on Tuesday, saying its offer represented compelling value for a company which would otherwise face challenges as a standalone firm.

Pfizer released a statement to set out its case for the deal, just hours before its chief executive appears in front of a British parliamentary committee to explain why he wants to acquire Britain's second largest drugmaker.

AstraZeneca has rejected a $106 billion bid from Pfizer but the US group is widely expected to return with a higher offer later this week.


Advertisement
more from Business

SBI defends $1 billion loan to Adani for Oz coal project, BJP steers clear of controversy

Amid controversy over sanctioning a $1 billion loan (nearly Rs 62,000 crore) to Adani Group, SBI said Thursday it had only signed a preliminary MoU and will disburse the money only after proper due diligence.

markets
Advertisement
Most Popular
Advertisement
Advertisement
Copyright © 2014 HT Media Limited. All Rights Reserved